title: Disease-modifying drugs for systemic sclerosis: why have we not found them yet?
authors.forename: Chris T
authors.initials: CT
authors.lastname: Derk
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D054316:Biomarkers, Pharmacological / Q000378:metabolism; D055808:Drug Discovery; D006801:Humans; D056747:Immunomodulation; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D053773:Transforming Growth Factor beta1 / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D054316:Biomarkers, Pharmacological; D053773:Transforming Growth Factor beta1; D009173:Mycophenolic Acid